Start-up focuses on nerve imaging

Article

Nervonix, a medical R&D company headquartered in Bozeman, MT, is cultivating technology that generates noninvasive 2D images of peripheral nerves. The images might ultimately be used to identify the location of nerves, providing the basis for pain

Nervonix, a medical R&D company headquartered in Bozeman, MT, is cultivating technology that generates noninvasive 2D images of peripheral nerves. The images might ultimately be used to identify the location of nerves, providing the basis for pain diagnosis and management by anesthesiologists, surgeons, and other clinicians, according to the company. A portable device is being designed to deliver real-time, high-resolution nerve images from a patient's bedside or the operating table. Nervonix is collaborating with Battelle Memorial Institute to develop the technology into a viable product, which could be commercially available as early as mid-2004, according to Nervonix. The company is now looking for commercial partners, OEMs, and distributors to assist in its development and marketing efforts.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.